Clicky

Fusion Pharmaceuticals Inc.(FUSN) News

Date Title
Jun 5 AstraZeneca completes Fusion Pharmaceuticals acquisition
May 31 Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
May 29 Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
May 10 Fusion Pharmaceuticals doses first subject in prostate cancer trial
May 9 Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer
May 7 Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates
May 2 Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 26 Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Apr 25 Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
Apr 23 Fusion Pharmaceuticals Inc. (FUSN) Ascends But Remains Behind Market: Some Facts to Note
Apr 17 Fusion Pharmaceuticals Inc. (FUSN) Stock Moves -0.09%: What You Should Know
Apr 11 Fusion Pharmaceuticals Inc. (FUSN) Flat As Market Gains: What You Should Know
Apr 11 Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) is definitely on the radar of institutional investors who own 46% of the company
Apr 9 Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
Mar 22 Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
Mar 20 Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates
Mar 20 Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
Mar 20 AstraZeneca (AZN) to Buy Fusion Pharmaceuticals for $2.4B
Mar 19 AstraZeneca acquires Fusion Pharmaceuticals in $2B deal
Mar 19 Stocks to Watch Tuesday: Super Micro, Fusion Pharmaceuticals, Nvidia, Unilever